These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 29922091)
41. Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis. Zhang S; Liu W; Hu B; Wang P; Lv X; Chen S; Shao Z Front Immunol; 2020; 11():1242. PubMed ID: 32714321 [No Abstract] [Full Text] [Related]
42. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors. Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453 [TBL] [Abstract][Full Text] [Related]
43. Prognostic value of periostin in multiple solid cancers: A systematic review with meta-analysis. Yang T; Deng Z; Pan Z; Qian Y; Yao W; Wang J J Cell Physiol; 2020 Mar; 235(3):2800-2808. PubMed ID: 31517399 [TBL] [Abstract][Full Text] [Related]
44. Prognostic and clinicopathological significance of SR-B1 in solid tumors: A meta-analysis. Wang M; Chao C; Luo G; Wang B; Zhan X; Di D; Qian Y; Zhang X Pathol Res Pract; 2020 Apr; 216(4):152849. PubMed ID: 32057516 [TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of dickkopf-1 overexpression in solid tumors: a meta-analysis. Liu Y; Tang W; Xie L; Wang J; Deng Y; Peng Q; Zhai L; Li S; Qin X Tumour Biol; 2014 Apr; 35(4):3145-54. PubMed ID: 24258111 [TBL] [Abstract][Full Text] [Related]
46. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389 [TBL] [Abstract][Full Text] [Related]
47. Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis. Zhang X; Fang C; Zhang G; Jiang F; Wang L; Hou J Oncotarget; 2017 Nov; 8(54):93156-93167. PubMed ID: 29190985 [TBL] [Abstract][Full Text] [Related]
48. Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis. Zhou L; Dai C; Tian T; Wang M; Lin S; Deng Y; Xu P; Hao Q; Wu Y; Yang T; Zhu W; Dai Z J Cancer; 2018; 9(23):4355-4362. PubMed ID: 30519340 [No Abstract] [Full Text] [Related]
49. Prognostic Role of High Stathmin 1 Expression in Patients with Solid Tumors: Evidence from a Meta-Analysis. Mao Q; Chen Z; Wang K; Xu R; Lu H; He X Cell Physiol Biochem; 2018; 50(1):66-78. PubMed ID: 30278466 [TBL] [Abstract][Full Text] [Related]
50. Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors: Systematic review, meta-analysis, and meta-regression. Wen S; Chen N; Hu Y; Huang L; Peng J; Yang M; Shen X; Song Y; Xu L Cancer Med; 2021 Mar; 10(5):1690-1714. PubMed ID: 33591628 [TBL] [Abstract][Full Text] [Related]
51. Prognostic role of high TET1 expression in patients with solid tumors: A meta-analysis. Ke Q; Wang K; Fan M; Li M; Luo G; Wang D Medicine (Baltimore); 2020 Oct; 99(44):e22863. PubMed ID: 33126331 [TBL] [Abstract][Full Text] [Related]
52. Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases. Ye Z; Zhang X; Luo Y; Li S; Huang L; Li Z; Li P; Chen G PLoS One; 2016; 11(9):e0163162. PubMed ID: 27657690 [TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of microRNA-100 in solid tumors: an updated meta-analysis. Wang J; Yu M; Guan S; Zhang G; Wang J; Cheng Y Onco Targets Ther; 2017; 10():493-502. PubMed ID: 28176958 [TBL] [Abstract][Full Text] [Related]
54. Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: a meta-analysis. Teng JJ; Zhang J; Zhang TY; Zhang S; Li BS Onco Targets Ther; 2016; 9():37-47. PubMed ID: 26730202 [TBL] [Abstract][Full Text] [Related]
55. The role of PTP1B (PTPN1) in the prognosis of solid tumors: A meta-analysis. Zhou J; Guo H; Zhang Y; Liu H; Dou Q Medicine (Baltimore); 2022 Oct; 101(40):e30826. PubMed ID: 36221386 [TBL] [Abstract][Full Text] [Related]
56. Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies. Wu J; Hu L; Chen M; Cao W; Chen H; He T Onco Targets Ther; 2016; 9():4277-88. PubMed ID: 27478385 [TBL] [Abstract][Full Text] [Related]
57. Prognostic role of HSF1 overexpression in solid tumors: a pooled analysis of 3,159 patients. Wan T; Shao J; Hu B; Liu G; Luo P; Zhou Y Onco Targets Ther; 2018; 11():383-393. PubMed ID: 29398920 [TBL] [Abstract][Full Text] [Related]
58. Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers: an updated meta-analysis. Sun DW; An L; Lv GY World J Surg Oncol; 2020 Jan; 18(1):9. PubMed ID: 31931816 [TBL] [Abstract][Full Text] [Related]
59. Evaluating the Prognostic Value of microRNA-203 in Solid Tumors Based on a Meta-Analysis and the Cancer Genome Atlas (TCGA) Datasets. Shao Y; Gu W; Ning Z; Song X; Pei H; Jiang J Cell Physiol Biochem; 2017; 41(4):1468-1480. PubMed ID: 28351024 [TBL] [Abstract][Full Text] [Related]
60. Prognositic value of CD73-adenosinergic pathway in solid tumor: A meta-analysis and systematic review. Wang R; Zhang Y; Lin X; Gao Y; Zhu Y Oncotarget; 2017 Aug; 8(34):57327-57336. PubMed ID: 28915673 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]